GSK-2793660

Modify Date: 2024-04-02 19:15:04

GSK-2793660 Structure
GSK-2793660 structure
Common Name GSK-2793660
CAS Number 1613458-70-0 Molecular Weight 357.45
Density N/A Boiling Point N/A
Molecular Formula C20H27N3O3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of GSK-2793660


GSK-2793660 is an oral, irreversible inhibitor of Cathepsin C (CTSC). GSK-2793660 can be used for the research of bronchiectasis[1][2].

 Names

Name GSK-2793660

 GSK-2793660 Biological Activity

Description GSK-2793660 is an oral, irreversible inhibitor of Cathepsin C (CTSC). GSK-2793660 can be used for the research of bronchiectasis[1][2].
Related Catalog
Target

Cathepsin C (CTSC)[1][2]

In Vivo GSK-2793660 is a cathepsin C (also known as dipeptidyl peptidase I enzyme) inhibitor for the reaearch of cystic fibrosis, non-cystic fibrosis bronchiectasis, anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis and bronchiectasis[1].
References

[1]. Szcześniak P, et al. The Synthesis of α,α-Disubstituted α-Amino Acids via Ichikawa Rearrangement. J Org Chem. 2016 Feb 5;81(3):1057-74.

[2]. Miller BE, et al. Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660). Br J Clin Pharmacol. 2017 Dec;83(12):2813-2820.

 Chemical & Physical Properties

Molecular Formula C20H27N3O3
Molecular Weight 357.45
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.